How to characterize co-administration of Sublingual Immunotherapy Tablets clinical practicalities, improving the patient tolerability and outcome

The great majority of patients consulting specialist physicians for allergic respiratory disease are polysensitized and thus may be potentially clinically polyallergic. However, management approaches to allergen immunotherapy (AIT) in polysensitized and polyallergic patients are not standardized. With new advancements in Allergy Immunotherapy (AIT) it is now possible to successfully treat patients with multiple respiratory allergies.

In this webinar, medical leaders in the treatment of allergies will discuss their key considerations and benefits of allergen-specific immunotherapy and highlight the potential of co-administration of SLIT-tablets with different allergens.

Join our panel of medical experts' in allergic respiratory diseases to learn:

• Clinical practicalities in the handling and management of patient tolerance at each stage of administration
• Impressions during initiation of treatment, including improvements in patient efficacy, safety and outcomes
• Challenges of patient adherence - opinion from clinical specialists on how to overcome sequential initiation challenges
• The clinician perspective on the treatment experience and outcomes, including the convenience of at-home self-administration and no up-dosing

Suitable for Allergists, ENTs, Pulmonologists, Dermatologists, Pharmacists, and those in primary care, join live to take part in a Q&A with our experts.

Prof. Natalija Novak: Specialist in Dermatology and Allergy, Professor at the Department of Dermatology and Allergy, University of Bonn, Germany. She is also head of the Experimental Allergology and Immunodermatology Research Group. Prof. Novak has published extensively in allergy with research interests including identification of biomarkers for atopy and mechanisms of action of allergy immunotherapy.

Prof. Sverre Steinsvåg: Specialist in ENT, Professor of Allergy and Sino-nasal disorders at University Hospital, Bergen, Norway. His main scientific interest is the link between the upper and lower airways. He is the co-author of the Norwegian Guidelines on AIT, and is a regular national and international lecturer about allergy, AIT and several ENT related topics.

Prof. Rémi Gagnon: Specialist in Allergy and Immunology, fellow of the Royal College of Physicians and Surgeons of Canada, and director and principal investigator at Clinique Spécialisée en Allergie de la Capitale (Allergy Specialized Clinic of the Capital) in Quebec City, Quebec. He also serves as president of the Association of Allergists and Immunologists of Quebec.

** The webinar is intended for healthcare professionals only **